About 115,000 results
Open links in new tab
  1. From immune evasion to activation: A new cancer vaccine strategy

    7 hours ago · A central obstacle is immune evasion: tumor cells suppress immune responses by expressing checkpoint proteins such as PD-L1 while failing to present sufficient antigenic …

  2. Inhalable nanotherapy can activate the immune system against checkpoint

    Jan 5, 2026 · Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the body's own cells. Cancer cells can use these …

  3. Unlocking NK cells: Novel checkpoint targets revolutionize cancer ...

    Aug 5, 2025 · A comprehensive analysis published in Reserch illuminates how cancer cells hijack immune checkpoints on natural killer (NK) cells to disable the body’s frontline defense system.

  4. The role of immune checkpoints in antitumor response: a …

    Dec 15, 2023 · This review provides an in-depth exploration of immune checkpoint molecules, their corresponding blocking antibodies, and their clinical applications.

  5. The present study was initiated by comparing publicly available transcription profiles of tumor tissues from responsive and resistant ICB-treated patients across various cancer types.

  6. Immune checkpoint blockade in cancer: current insights and …

    Jan 2, 2026 · The advent of immune checkpoint inhibitors has yielded durable clinical responses in diverse malignancies, substantiating their role as foundational agents in cancer therapy. …

  7. How Does Cancer Evade the Immune System? - Biology Insights

    Dec 16, 2025 · Even if a T-cell recognizes a cancer cell, the tumor employs a second strategy to shut down the immune attack through molecular signaling. This involves exploiting natural …

  8. How Cancer Tumors Hijack the Body’s Defense System

    May 10, 2024 · Authors note that tumors likely employ a variety of strategies to evade immune detection. But the discovery could lead to a new approach for targeted cancer therapies.

  9. Clinical Trial of Personalized Cancer Vaccine Demonstrates …

    Dec 12, 2025 · The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory biomaterial-based cancer vaccine, in a cohort of 21 patients …

  10. Linavonkibart demonstrates early potential to overcome resistance …

    1 day ago · According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody …